June 10, 2025 – Talk Bio

National Resilience Restructures Manufacturing Footprint, Closes 6 of 10 Plants

2 months ago talkbio0Tagged CDMO, Manufacturing, National Resilience, overcapacity, restructuring

National Resilience; manufacturing; CDMO; restructuring; overcapacity; biotech

Recursion Pharmaceuticals Lays Off 20% of Staff Amid Pipeline Cutbacks

2 months ago talkbio0Tagged Infrequent, layoffs, Neoplasms, pipeline cutbacks, Recursion, restructuring

Recursion Pharmaceuticals; layoffs; pipeline cutbacks; biotech; workforce reduction; restructuring; rare diseases; oncology

All innuendo and conspiracy: RFK Jr.’s vaccine advisory overhaul undermines vaccine confidence, experts say

2 months ago talkbio0Tagged ACIP, advisory, conspiracy, overhaul, public health medicine (field), RFK Jr., Self Confidence, Vaccines

RFK Jr.; vaccine advisory; ACIP; public health; conspiracy; confidence; overhaul

Axsome Plots New Fibromyalgia Trial After FDA Refuses Review of Former Pfizer Candidate

2 months ago talkbio0Tagged Analgesics, AXS-14, Axsome, Clinical Trials, esreboxetine, Fibromyalgia, File (record), Pfizer, refusal, trial design, United States Food and Drug Administration

Axsome Therapeutics; esreboxetine; fibromyalgia; FDA; refusal to file; clinical trial; Pfizer; AXS-14; trial design; pain medicine

Odyssey Therapeutics Abandons IPO Plans in Latest Sign of Tough Environment for Biotech Listings

2 months ago talkbio0Tagged Autoimmune, IPO, Market, Odyssey, seconds, turbulence, Withdraw (activity)

Odyssey Therapeutics; IPO; biotech; withdrawal; SEC; market turbulence; autoimmune

RFK Jr. Ousts All Members of CDC’s Vaccine Advisory Panel in ‘Clean Sweep’

2 months ago talkbio0Tagged ACIP, Centers for Disease Control and Prevention (U.S.), CHARGE Syndrome, clean sweep, public trust, RFK Jr., Robert F. Kennedy Jr., vaccine advisory panel

RFK Jr.; CDC; vaccine advisory panel; Robert F. Kennedy Jr.; ACIP; clean sweep; public trust; HHS

NewAmsterdam Reports Cholesterol Drug Obicetrapib May Slow Alzheimer’s Biomarker Buildup

2 months ago talkbio0Tagged Alzheimer 's disease, Apolipoprotein E4, Biological Markers, CETP, cholesterol ester transfer protein inhibitor, NewAmsterdam Pharma, Obicetrapib, p-tau217, Phase 3

NewAmsterdam Pharma; obicetrapib; cholesterol ester transfer protein inhibitor (CETP); Alzheimer’s disease biomarkers; p-tau217; ApoE4; BROADWAY trial; Phase 3

Metsera Reports Once-Monthly Amylin Analogue Matches GLP-1 Efficacy in Early Phase 1 Results

2 months ago talkbio0Tagged Amylin, Clinical Trials, Glucagon-Like Peptide 1, MET-233i, Metsera, Obesity, once-monthly, Phase 1 (qualifier value), Weight-Loss

Metsera; MET-233i; amylin; obesity; weight-loss; GLP-1; once-monthly; clinical trial; phase 1